Metformin does not alter the risk of lung cancer: A case-control analysis

Lung Cancer

Volumn 78, Issue 2, 2012, Pages 133-137

  Bodmer, Michael ^a,b   Becker, Claudia ^a   Jick, Susan S ^c   Meier, Christoph R ^a,b,c  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antidiabetic drugs; Insulin; Lung cancer; Metformin; Sulfonylureas

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; GLYCOSIDASE INHIBITOR; INSULIN; METFORMIN; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CANCER RISK; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GEOGRAPHIC DISTRIBUTION; GLYCEMIC CONTROL; HUMAN; INCIDENTAL FINDING; INSULIN TREATMENT; LONG TERM CARE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PRESCRIPTION; PRIORITY JOURNAL; RISK REDUCTION; SEX DIFFERENCE; SMOKING; TUBERCULOSIS;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; METFORMIN; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK; SULFONYLUREA COMPOUNDS;

EID: 84867404716     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2012.08.010     Document Type: Article

References (26)

1. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics. CA Cancer J Clin 2010, 60:277-300.
2. Mulshine J.L., Sullivan D.C. Clinical practice, lung cancer screening. N Engl J Med 2005, 352:2714-2720.
3. Atchison E.A., Gridley G., Carreon J.D., Leitzmann M.F., McGlynn K.A. Risk of cancer in a large cohort of U.S. veterans with diabetes. Int J Cancer 2011, 128:635-643.
4. Ogunleye A.A., Ogston S.A., Morris A.D., Evans J.M. A cohort study of the risk of cancer associated with type 2 diabetes. Br J Cancer 2009, 101:1199-1201.
5. Rousseau M.C., Parent M.E., Pollak M.N., Siemiatycki J. Diabetes mellitus and cancer risk in a population-based case-control study among men from Montreal, Canada. Int J Cancer 2006, 118:2105-2109.
6. Ehrlich S.F., Quesenberry C.P., Van Den Eeden S.K., Shan J., Ferrara A. Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer. Diabetes Care 2010, 33:55-60.
7. Hall G.C., Roberts C.M., Boulis M., Mo J., MacRae K.D. Diabetes and the risk of lung cancer. Diabetes Care 2005, 28:590-594.
8. Lai S.W., Liao K.F., Chen P.C., Tsai P.Y., Hsieh D.P., Chen C.C. Antidiabetes drugs correlate with decreased risk of lung cancer: a population-based observation in Taiwan. Clin Lung Cancer 2012, 13:143-148.
9. Kabat G.C., Kim M., Hunt J.R., Chlebowski R.T., Rohan T.E. Body mass index and waist circumference in relation to lung cancer risk in the Women's Health Initiative. Am J Epidemiol 2008, 168:158-169.
10. Dowling R.J., Goodwin P.J., Stambolic V. Understanding the benefit of metformin use in cancer treatment. BMC Med 2011, 9:33.
11. Noto H., Goto A., Tsujimoto T., Noda M. Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis. PLoS ONE 2012, 7:e33411.
12. Shaw R.J., Lamia K.A., Vasquez D., Koo S.H., Bardeesy N., Depinho R.A., et al. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 2005, 310:1642-1646.
13. Wu N., Gu C., Gu H., Hu H., Han Y., Li Q. Metformin induces apoptosis of lung cancer cells through activating JNK/p38 MAPK pathway and GADD153. Neoplasma 2011, 58:482-490.
14. Algire C., Zakikhani M., Blouin M.J., Shuai J.H., Pollak M. Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth. Endocr Relat Cancer 2008, 15:833-839.
15. Memmott R.M., Mercado J.R., Maier C.R., Kawabata S., Fox S.D., Dennis P.A. Metformin prevents tobacco carcinogen-induced lung tumorigenesis. Cancer Prev Res (Phila) 2010, 3:1066-1076.
16. Tan B.X., Yao W.X., Ge J., Peng X.C., Du X.B., Zhang R., et al. Prognostic influence of metformin as first-line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes. Cancer 2011, 117:5103-5111.
17. Wood L., Martinez C. The general practice research database: role in pharmacovigilance. Drug Saf 2004, 27:871-881.
18. Jick S.S., Kaye J.A., Vasilakis-Scaramozza C., Garcia Rodriguez L.A., Ruigomez A., Meier C.R., et al. Validity of the general practice research database. Pharmacotherapy 2003, 23:686-689.
19. Lawrenson R., Williams T., Farmer R. Clinical information for research; the use of general practice databases. J Public Health Med 1999, 21:299-304.
20. Brauchli Y.B., Jick S.S., Curtin F., Meier C.R. Association between use of thiazolidinediones or other oral antidiabetics and psoriasis: a population based case-control study. J Am Acad Dermatol 2008, 58:421-429.
21. Meier C., Kraenzlin M.E., Bodmer M., Jick S.S., Jick H., Meier C.R. Use of thiazolidinediones and fracture risk. Arch Intern Med 2008, 168:820-825.
22. Bodmer M., Meier C., Krahenbuhl S., Jick S.S., Meier C.R. Long-term metformin use is associated with decreased risk of breast cancer. Diabetes Care 2010, 33:1304-1308.
23. Azoulay L., Dell'aniello S., Gagnon B., Pollak M., Suissa S. Metformin and the incidence of prostate cancer in patients with type 2 diabetes. Cancer Epidemiol Biomarkers Prev 2011, 20:337-344.
24. Bodmer M., Becker C., Meier C., Jick S.S., Meier C.R. Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis. Cancer Epidemiol Biomarkers Prev 2012, 21:280-286.
25. Bodmer M., Becker C., Meier C., Jick S.S., Meier C.R. Use of metformin and the risk of ovarian cancer: a case-control analysis. Gynecol Oncol 2011, 123:200-204.
26. Jick H., Jick S.S., Derby L.E. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 1991, 302:766-768.